Current Issue


  • Healthcare service utilization and epidemiology of AD in Israel
    Guy Shalom, Meir Babaev, Khalaf Kridin, Yochai Schonmann, Amir Horev, Jacob Dreiher, Michal Shani, Shmuel Tiosano, Shani Fisher, Doron Comaneshter, Arnon D. Cohen
  • An increased burden of healthcare utilization across the entire spectrum of healthcare serveds is requried for atopic dermatitis patients compared with controls.

  • Eye complications during dupilumab treatment for severe AD
    Lina U. Ivert, Carl-Fredrik Wahlgren, Lena Ivert, Maria Lundqvist, Maria Bradley
  • The risk of aderse events from the eyes and recurrence of herpes virus infections should be kept in mind when using dupilumab.
  • Swedish cost-utility analysis of calcipotriol/betamethasone dipropionate aerosol foam
    Albert Duvetorp, Lars-Åke Levin, Emma Engerstedt Mattsson, Lasse Ryttig
  • The superior efficacy of Cal/BD foam over ointment led to fewer consultation visits, a decreased risk of progressing to second-line therapy, and lower total costs.
  • Modifiable risk-factors for keratinocyte cancers in Australia
    Lina Maria Serna-Higuita, Simone L. Harrison, Petra Buttner, Margaret Glasby, Beverly A. Raasch, Angelika Iftner, Claus Garbe, Peter Martus, Thomas Iftner
  • Increasing age, lower academic qualifications, freckling during adolescence, solar lentiginous, propensity to sunburn and high-cumulative sun exposure increse the risk of keratinocyte cancer.
  • Itch in psoriasis
    Radomir Reszke, Rafał Białynicki-Birula, Jacek C. Szepietowski
  • The majority of psoriatic patients experience chronic itch. This study evaluated the prevalence and clinical charactertistics of chronic itch in a cohort of psoriatic subjects.
  • Ixekizumab-induced psoriasiform eruption
    Tomohiro Oiwa, Mafumi Fujita, Sawako Takase, Youichi Nishimura, Miyuki Ota, Kayo Okada, Takao Tachibana
  • The first case report of psoriasiform eruptions induced by ixekizumab.
  • COL17A1 variant alters splicing and causes JEB
    Julia Hoffmann, Federica Casetti, Antonia Reimer, Juna Leppert, Gabriele Grüninger, Cristina Has
  • This study proves the pathogenicity of the hypomorphic COL17A1 variant associated with mild to moderate JEB. The in silico prediction of splicing alteration was confirmed by sequencing the mRNA; surprisingly the prediction with a relataively low score was experimentally proven.


    QUIZ - 2019-02-05
    An Asymptomatic Verrucous Nodule on the Scrotum: A Quiz
    Yue-Tong Qian, Jia-Wei Liu, Wei Liu, Dong-Lai Ma
    QUIZ - 2019-01-15
    Diffuse Purpura on the Abdomen and Extremities: A Quiz
    Grigorios Theodosiou, Iva Johansson, Åke Svensson
    Show more quizzes »

    This is ActaDV

    An international peer-reviewed journal for clinical and experimental research in the field of dermatology and venereology.

    Published by the Non-Profit Organization Society for Publication of Acta Dermato-Venereologica

    The official Journal of:
    European Society for Dermatology and Psychiatry

    Affiliated with:
    International Forum for the Study of Itch

    Go to Content »

    ISI Impact Factor 2017: 3.127 H Index: 72

    SCImago Journal & Country Rank
    Sign up for e-mail alerts and be notified when the next issue is released.

    By sending this form you confirm that your personal data will be stored with regards to the privacy policy.

    From current issue: 4 (99)

    Healthcare Service Utilization by 116,816 Patients with Atopic Dermatitis in Israel
    Guy Shalom, Meir Babaev, Khalaf Kridin, Yochai Schonmann, Amir Horev, Jacob Dreiher, Michal Shani, Shmuel Tiosano, Shani Fisher, Doron Comaneshter, Arnon D. Cohen
    Defining the epidemiology and healthcare service utilization in relation to atopic dermatitis is warranted to allow the incorporation of newly introduced treatments for atopic dermatitis. In a large group of 116,816 patients with atopic dermatitis, the disease was associated with an increased burden of healthcare utilization in a dose-response manner according to disease severity. These data quantifies healthcare utilization by patients with AD and can facilitate improved incorporation of innovative treatments into the healthcare system.
    Pages: 370-374
    Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
    Lina U. Ivert, Carl-Fredrik Wahlgren, Lena Ivert, Maria Lundqvist, Maria Bradley
    This case series describes ten patients treated with dupilumab, where eye complications such as conjunctivitis were common, suggesting the importance of close collaboration with an ophthalmologist, especially among patients with severe, long-lasting AD and/or previous eye disease.
    Pages: 375-378
    Volume 95, Issue 1
    Evidence-based Danish Guidelines for the Treatment of Malassezia-related Skin Diseases
    Marianne Hald, Maiken C. Arendrup, Else L. Svejgaard, Rune Lindskov, Erik K. Foged, Ditte Marie L. Saunte
    Volume 92, Issue 2
    Common Neuropathic Itch Syndromes
    Anne Louise Oaklander
    Volume 93, Issue 3
    Skin pH: From Basic SciencE to Basic Skin Care
    Saba M. Ali, Gil Yosipovitch
    Volume 92, Issue 1
    Rosacea Treatment with Intermediate-dose Isotretinoin: Follow-up with Erythema and Sebum Measurements
    Meltem Uslu, Ekin Şavk, Göksun Karaman, Neslihan Şendur
    Adult Patients with Atopic Eczema have a High Burden of Psychiatric Disease: A Finnish Nationwide Registry Study
    Saana Kauppi, Jari Jokelainen, Markku Timonen, Kaisa Tasanen, Laura Huilaja
    European S2k Guideline on Chronic Pruritus
    Elke Weisshaar, Jacek C. Szepietowski, Florence J. Dalgard, Simone Garcovich, Uwe Gieler, Ana M. Giménez-Arnau, Julien Lambert, Tabi Leslie, Thomas Mettang, Laurent Misery, Ekin Şavk, Markus Streit, Erwin Tschachler, Erwin Tschachler, Joanna Wallengren, Sonja Ständer
    Stable Firm Pink Papules on a Woman in her 60s: A Quiz
    Catherine Baker, Katherine R. Lee, Anh Khoa Pham, Robert E. LeBlanc, Joi B. Carter
    Gliptin-associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4/CD26 in Bullous Pemphigoid
    Outi Lindgren, Outi Varpuluoma, Jussi Tuusa, Jorma Ilonen, Laura Huilaja, Nina Kokkonen, Kaisa Tasanen
    Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics
    Federico Bardazzi, Michela Starace, Francesca Bruni, Michela Magnano, Bianca Maria Piraccini, Aurora Alessandrini